-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On 10x Genomics with Neutral Rating, Announces Price Target of $15

Benzinga·09/11/2025 11:23:17
Listen to the news
Piper Sandler analyst David Westenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Neutral rating and announces Price Target of $15.